2020 annual financial data

Elicio Therapeutics 2020 Financial results

Direct answer

Revenue was 2,880,000 USD.

Operating income was -55,273,000 USD and net income was -80,107,000 USD.
Operating cash flow was -22,888,000 USD.

Get free Elicio Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
2,880,000 USD
Operating income
-55,273,000 USD
Net income
-80,107,000 USD
Operating cash flow
-22,888,000 USD